International Journal of Biological Macromolecules Submission Guide

If you are preparing an International Journal of Biological Macromolecules submission, the main risk is not the upload portal. The main risk is sending a paper that still feels split between chemistry and biology instead of fully integrated.

The journal is realistic when four things are already true:

• the macromolecule is fully characterized with methods that match the claim
• the biological function is demonstrated, not implied
• the manuscript explains why the result matters for a biological or biomedical use case
• the package reads like a finished study rather than a first report with obvious gaps

If one of those conditions is weak, the paper often stalls early.

International Journal of Biological Macromolecules is broad across proteins, polysaccharides, biomaterials, and related biological macromolecules, but the editorial filter is narrower than the scope page sounds. Editors are usually asking:

• is this really a biological macromolecules paper rather than a general polymer or analytical paper?
• is the structure characterized well enough to support the biological claim?
• is the biological result substantial enough to justify the venue?
• does the paper connect structure, function, and application in a way the readership will care about?

That means the journal is not a free pass for studies that are only halfway into biology. A materials-heavy manuscript with one viability assay or one antioxidant assay still looks weak here. The paper needs to show that the macromolecule matters biologically and that the experiments are designed to prove that clearly.

Before you worry about formatting, decide whether the paper is shaped correctly for this journal.

Source: Elsevier guide for authors, International Journal of Biological Macromolecules

Ask these questions before you submit:

• if an editor read only the title, abstract, and first figure, would the paper already look biologically relevant?
• does the manuscript show both characterization quality and meaningful function?
• would a reviewer immediately ask for missing controls or missing structure data?
• is the application context clear enough that the journal fit feels obvious?

If those answers are uncertain, the package is usually still early.

The title should state the actual advance, not only the material studied. The abstract should make the structure-function relationship visible quickly. If the reader finishes the abstract and still cannot tell what is new, what was measured, and why it matters biologically, the submission is weak before review even starts.

This journal benefits from explicit structure. A strong package usually includes:

• one scheme or figure showing the macromolecule design or preparation
• one table summarizing key characterization results
• one figure that makes the biological effect obvious
• one figure or table that ties the biological result back to the structural claim

If those pieces are scattered or missing, the manuscript reads like a set of experiments instead of a finished paper.

This is where a lot of manuscripts lose credibility. Before you submit, check:

• are the controls appropriate for each biological assay?
• are statistical methods explicit and sample sizes clear?
• does the manuscript distinguish screening results from mechanistic results?
• are the conditions realistic enough to support the application claim?

Editors can usually tell quickly when the biological section was added late.

The cover letter should do three things:

• state the central result plainly
• explain why the work belongs in this journal rather than a narrower chemistry or materials venue
• make the biological relevance obvious without exaggeration

The best version sounds like a practical editorial memo, not a marketing pitch.

Before you upload, ask one blunt question:

• if an editor saw only the title, abstract, characterization table, and the first biological result figure, would the structure-function story already feel complete enough to review?

If the answer is no, fix the package before submission.

• one clear claim about what the macromolecule does better or differently
• one obvious structure-function connection
• one credible application lane
• full characterization that supports the headline claim
• biological data that make the editorial case easy to see

In our pre-submission review work with manuscripts targeting International Journal of Biological Macromolecules, five patterns generate the most consistent desk rejections worth knowing before submission.

• Macromolecule paper with structural data but no biological function (roughly 35%). The guide for authors positions the journal as publishing work on biological macromolecules that connects structure to biological function and application, requiring that submissions demonstrate the biological relevance of the macromolecular work rather than providing structural characterization alone. In our experience, roughly 35% of desk rejections involve manuscripts that provide strong physicochemical characterization of a protein, polysaccharide, or biopolymer without demonstrating meaningful biological function through controls and assays that would satisfy a biologically focused reviewer. Editors specifically screen for manuscripts where the structure-function connection is established in the data, not inferred from the characterization table.

• Application claim runs ahead of the biological evidence shown (roughly 25%). In our experience, we find that roughly 25% of submissions propose biomedical, antimicrobial, or drug delivery applications in the discussion that are not yet supported by the biological data shown in the results, with the application relevance resting on a single screening assay or on speculative reasoning about the macromolecule's properties. In practice, editors consistently screen for manuscripts where the application case is credible and supported by the existing evidence package, because application overclaim from limited assays is among the most common reviewer objections at IJBM.

• Characterization incomplete for the structural claim being made (roughly 20%). In our experience, roughly 20% of submissions present biological macromolecule data without the characterization package appropriate for the macromolecule type and claim: for polysaccharides this typically means missing composition, molecular weight, or linkage evidence; for peptides or proteins it means absent purity confirmation or sequence validation relevant to the interpretation. Editors consistently screen for manuscripts where the characterization supports the headline claim, because incomplete structural evidence makes the biological data less credible regardless of the assay quality.

• Chemistry paper with the IJBM application frame bolted on late (roughly 15%). In our experience, roughly 15% of submissions are primarily polymer, food science, or analytical chemistry manuscripts that reference biological function or application in the introduction and discussion without integrating biological evidence throughout the paper. In our analysis of submission difficulties at IJBM, this pattern is most identifiable when the biological section consists of one generic assay appended to an otherwise chemistry-focused manuscript, rather than being integral to the structure-function argument.

• Cover letter names the macromolecule but omits the biological case (roughly 10%). In our experience, roughly 10% of submissions arrive with cover letters that describe the macromolecule studied and the characterization approach without stating what the biological function or application result demonstrates and why it matters for the journal's readership. Editors explicitly consider whether the cover letter makes the biological relevance case before routing the paper for specialist review.

Before submitting to International Journal of Biological Macromolecules, an IJBM submission readiness check identifies whether your structure-function evidence, characterization package, and application framing meet the editorial bar before you commit to the submission.

1. International Journal of Biological Macromolecules journal profile, Manusights.
2. How to choose the right journal for your paper, Manusights.

If you are still deciding whether the fit is real, compare this guide with Is International Journal of Biological Macromolecules a Good Journal? and How to Avoid Desk Rejection at International Journal of Biological Macromolecules. If you want a direct readiness call before you submit, IJBM submission readiness check is the best next step.

• SciRev: reviewer timeline data